NYC conference Nov. 3 features leading entrepreneurs

Entrepreneurs will gather to hear fireside chats with top business leaders, enjoy multiple networking and engagement opportunities and hear startup pitches at Entrepreneurship at Cornell’s Eclectic Convergence 2023.

Around Cornell

‘Food is Medicine’ research is key to chronic disease care

An American Heart Association Presidential Advisory outlines an ambitious plan to increase rigorous research on initiatives aimed at providing food as medicine for chronic conditions.

Student hackathons focus on food, ag, animals, health and business services

The hackathons, run by Entrepreneurship at Cornell, are open to undergraduate and graduate students from any field and major and take place from Friday evenings through Sunday afternoon.

Around Cornell

Greg Morrisett reappointed Cornell Tech dean

Greg Morrisett has been appointed to a second term as the Jack and Rilla Neafsey Dean and Vice Provost of Cornell Tech, Provost Michael I. Kotlikoff announced Oct. 9.

Newman, Plowright, Wolchok elected to National Academy of Medicine

Two faculty members from Weill Cornell Medicine and one from the College of Veterinary Medicine have been elected to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.

The 2030 Project invites proposals for annual research-to-impact grants, first round awarded

The 2023 research-to-impact projects aim to accelerate collaborative approaches needed  to combat the climate crisis through practical science. 

Around Cornell

Israel Cidon named director of Jacobs Technion-Cornell Institute

Israel Cidon, former dean of the Andrew and Erna Viterbi Faculty of Electrical and Computer Engineering at Technion-Israel Institute of Technology, has joined Cornell Tech as director of the Joan and Irwin Jacobs Technion-Cornell Institute.

Combination therapy promising against ‘cold’ breast cancer tumors

Researchers at Weill Cornell Medicine have found that radiation therapy combined with two types of immunotherapy can control tumors in preclinical models of triple-negative breast cancer, which is typically resistant to immunotherapy alone.

Cornell-EDF projects to study extreme urban heat, ag sustainability

The Cornell Atkinson Center for Sustainability launches two new research partnerships with EDF. 

Around Cornell